Kai Kang

59 papers and 1.4k indexed citations i.

Kai Kang has authored 59 papers that have received a total of 1.4k indexed citations. This includes 21 papers in Molecular Biology, 15 papers in Infectious Diseases and 13 papers in Neurology. The topics of these papers are COVID-19 Clinical Research Studies (12 papers), Long-Term Effects of COVID-19 (11 papers) and Heme Oxygenase-1 and Carbon Monoxide (8 papers). Kai Kang is often cited by papers focused on COVID-19 Clinical Research Studies (12 papers), Long-Term Effects of COVID-19 (11 papers) and Heme Oxygenase-1 and Carbon Monoxide (8 papers) and collaborates with scholars based in China, New Zealand and United States. Kai Kang's co-authors include Shangha Pan, Mingyan Zhao, Dongsheng Fei, Xianglin Meng and Kaijiang Yu and has published in prestigious journals such as PLoS ONE, Biomaterials and Frontiers in Immunology